The UK’s Cineworld Group has agreed to buy US theater operator Regal Entertainment to expand into the biggest movie market. The deal values Regal at US$3.6 billion.
The US$23-a-share deal comes a week after the companies confirmed news reports of takeover discussions, jolting cinema-operator stocks. The price represents a 26% premium to Regal’s close on November 27, the day before discussions became public.
Cineworld will gain opportunities for growth outside Britain, where consumer spending is falling ahead of the country’s exit from the European Union. Movie-theater operators are consolidating to wring out costs and afford reclining chairs and expanded food-and-drink options to entice customers away from their Netflix binges at home.
“The joint group is going to create the best place to watch a movie,” Cineworld Chief Executive Officer Mooky Greidinger said in an interview Tuesday, December 5. Cinemas remain the “key drivers” of the industry, not home entertainment, he said. “The place to premier the big movies is in the cinemas.”
The company is expanding in the US as the country’s theater chains are struggling with stagnating movie attendance. Many films this year have failed to meet expectations at the box office, and the summer season — usually the most lucrative for the industry — was the worst since 2006.
Full Content: LA Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas